Lionnel Geoffrois, MD

Articles by Lionnel Geoffrois, MD

UFT and Oral Calcium Folinate as First-Line Chemotherapy for Metastatic Gastric Cancer

ByAlain Ravaud, MD, PhD,Markus M. Borner, MD,Jan H. M. Schellens, MD,Lionnel Geoffrois, MD,Patrick Schöffski, MD,Jantien Wanders, MD,Axel R. Hanauske, MD, PhD

July 1st 1999

Locally advanced or metastatic adenocarcinoma of the stomach still carries a poor prognosis, with 5-year survival rates of < 15%. Palliative chemotherapeutic regimens for this disease are largely 5-FU–based. We

Latest Updated Articles

UFT and Oral Calcium Folinate as First-Line Chemotherapy for Metastatic Gastric Cancer
July 1st 1999

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)